Long-term phenotypic correction in factor IX knockout mice by using phiC31 integrase-mediated gene therapy

Kinetics and Longevity of ϕC31 Integrase in Mouse Liver and Cultured Cells

(2010) Christopher L. Chavez et al.   HUMAN GENE THERAPY

Impact of Hydrodynamic Injection and phiC31 Integrase on Tumor Latency in a Mouse Model of MYC-Induced Hepatocellular Carcinoma

(2010) Lauren E. Woodard et al.   PLoS One

Progress toward liver-based gene therapy

(2009) Takeshi Suda et al.   HEPATOLOGY RESEARCH

Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV

(2009) T. GUI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Image-guided, Lobe-specific Hydrodynamic Gene Delivery to Swine Liver

(2009) Kenya Kamimura et al.   MOLECULAR THERAPY

Gene Therapy for Hemophilia: Clinical Trials and Technical Tribulations

(2009) Nicholas Viiala et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Gene therapy for haemophilia

(2008) Samuel L. Murphy et al.   BRITISH JOURNAL OF HAEMATOLOGY

Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human

(2008) S E Khorsandi et al.   CANCER GENE THERAPY

Mutational Derivatives of PhiC31 Integrase With Increased Efficiency and Specificity

(2008) Annahita Keravala et al.   MOLECULAR THERAPY

Optimization of Self-complementary AAV Vectors for Liver-directed Expression Results in Sustained Correction of Hemophilia B at Low Vector Dose

(2007) Zhijian Wu et al.   MOLECULAR THERAPY